{"id":203256,"name":"SEMA4 (FORMERLY KNOWN AS MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4))","slug":"sema4-formerly-known-as-mount-sinai-genomics-inc-dba-sema4","state":"CT","country":"United States of America","description":"Clinical genetic testing services","totalSpending":128250,"filings":22,"yearlySpending":[{"year":2019,"income":45000},{"year":2020,"income":15750},{"year":2021,"income":45000},{"year":2022,"income":22500},{"year":2023,"income":0}],"issues":["MED","CPT","HCR","MMM","TAX"],"firms":["IPOLICY SOLUTIONS"],"lobbyists":["JENNIFER LEIB","MEGAN ANDERSON BROOKS","JAY QIU"],"govEntities":["Food & Drug Administration (FDA)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act","No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act\nDraft Guidance: Developing and Labeling In vitro Companion Diagnostic Devices for a Specific Group or Class of Oncology Therapeu","No bill #, reforming Sec. 101 of the Patent Act","No bill #, reforming Sec. 101 of the Patent Act","Innovation in precision medicine"],"years":[2019,2020,2021,2022,2023]}